Literature DB >> 10961416

Vascular aspects in Alzheimer's disease.

I Skoog1.   

Abstract

Alzheimer's disease is a primary degenerative dementia and is not considered to be of vascular origin. Furthermore, severe cerebrovascular diseases are generally exclusionary for the clinical diagnosis. During recent years both epidemiological and neuropathological studies have suggested an association between Alzheimer's disease and several vascular risk factors, such as hypertension, inheritance of the apolipoprotein E epsilon4 allele, coronary heart disease, diabetes mellitus, ischaemic white matter lesions and generalised atherosclerosis. These findings may reflect an overdiagnosis of Alzheimer's disease in individuals with silent cerebrovascular disease or that cerebrovascular disease may affects the clinical expression of Alzheimer's disease. Further possibilities include that Alzheimer's disease may increase the risk of vascular disease or that vascular disease may stimulate the Alzheimer's disease process. Similar mechanisms may also be involved in the pathogenesis of both disorders, such as disturbances in the renin-angiotensin system, apoptosis, and psychological stress.

Entities:  

Mesh:

Year:  2000        PMID: 10961416     DOI: 10.1007/978-3-7091-6781-6_6

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  21 in total

1.  Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort.

Authors:  Adam M Brickman; Christiane Reitz; José A Luchsinger; Jennifer J Manly; Nicole Schupf; Jordan Muraskin; Charles DeCarli; Truman R Brown; Richard Mayeux
Journal:  Arch Neurol       Date:  2010-05

Review 2.  Does the angiotensin II receptor antagonist losartan improve cognitive function?

Authors:  Michele A Tedesco; Gennaro Ratti; Giovanni Di Salvo; Francesco Natale
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

4.  Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients.

Authors:  Fernando E Taragano; Ricardo F Allegri; Hugo Krupitzki; Diego R Sarasola; Cecilia M Serrano; Leandro Loñ; Constantine G Lyketsos
Journal:  J Clin Psychiatry       Date:  2009-03-24       Impact factor: 4.384

5.  Magnetic resonance imaging traits in siblings discordant for Alzheimer disease.

Authors:  Karen T Cuenco; Robert C Green; J Zhang; Kathryn Lunetta; Porat M Erlich; L Adrienne Cupples; Lindsay A Farrer; Charles DeCarli
Journal:  J Neuroimaging       Date:  2008-07       Impact factor: 2.486

Review 6.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

Review 7.  Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.

Authors:  Jessika Royea; Edith Hamel
Journal:  Geroscience       Date:  2020-07-22       Impact factor: 7.713

8.  Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging.

Authors:  Maria Vassilaki; Ruth H Cha; Jeremiah A Aakre; Terry M Therneau; Yonas E Geda; Michelle M Mielke; David S Knopman; Ronald C Petersen; Rosebud O Roberts
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Coronary heart disease is associated with non-amnestic mild cognitive impairment.

Authors:  Rosebud O Roberts; David S Knopman; Yonas E Geda; Ruth H Cha; Véronique L Roger; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2008-12-16       Impact factor: 4.673

Review 10.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.